SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-255304
Filing Date
2019-09-26
Accepted
2019-09-26 09:01:10
Documents
14
Period of Report
2019-09-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d803680d8k.htm   iXBRL 8-K 28912
2 EX-99.1 d803680dex991.htm EX-99.1 14493
6 GRAPHIC g803680g0926035727504.jpg GRAPHIC 3525
  Complete submission text file 0001193125-19-255304.txt   176940

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20190926.xsd EX-101.SCH 3070
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20190926_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20190926_pre.xml EX-101.PRE 11408
13 EXTRACTED XBRL INSTANCE DOCUMENT d803680d8k_htm.xml XML 3395
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191115664
SIC: 2834 Pharmaceutical Preparations